$URGN stock has now fallen 13% today, according to our price data from Polygon. There has been approximately $21,131,074 of trading volume.
Here is what we see in our data on $URGN (you can track the company live on Quiver's $URGN stock page):
$URGN Insider Trading Activity
$URGN insiders have traded $URGN stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $URGN stock by insiders over the last 6 months:
- MARK SCHOENBERG (Chief Medical Officer) has made 0 purchases and 5 sales selling 86,770 shares for an estimated $3,784,896.
- JASON DREW SMITH (General Counsel) sold 1,519 shares for an estimated $64,618
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$URGN Hedge Fund Activity
We have seen 93 institutional investors add shares of $URGN stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TORONTO DOMINION BANK removed 2,616,714 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $96,295,075
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,703,949 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $62,705,323
- POINT72 ASSET MANAGEMENT, L.P. added 1,525,549 shares (+inf%) to their portfolio in Q2 2026, for an estimated $56,140,203
- J. GOLDMAN & CO LP removed 726,095 shares (-77.3%) from their portfolio in Q2 2026, for an estimated $26,720,295
- TCG CROSSOVER MANAGEMENT, LLC removed 405,365 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $14,917,431
- SG AMERICAS SECURITIES, LLC added 395,060 shares (+23.8%) to their portfolio in Q2 2026, for an estimated $14,538,207
- BLACKROCK, INC. added 355,894 shares (+12.5%) to their portfolio in Q2 2026, for an estimated $13,096,899
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$URGN Government Contracts
We have seen $32,844 of award payments to $URGN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ZUSDURI MEDICATION: $32,844
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$URGN Price Targets
Multiple analysts have issued price targets for $URGN recently. We have seen 2 analysts offer price targets for $URGN in the last 6 months, with a median target of $42.5.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $45.0 on 06/03/2026
- Leland Gershell from Oppenheimer set a target price of $40.0 on 05/07/2026
You can track data on $URGN on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
